All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 113 of 206 pages ‹ First < 111 112 113 114 115 > Last ›
HSL5092
 Rognstad S, Straand J.
 [The withdrawal of Vioxx: how did the patients react?]
 Tidsskr Nor Laegeforen 2006 May 11;126:(10):1326-7
 
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1377273
HSL5135
 Check E.
 Are rich nations up for drug reform?
 
Nature 2006 May 11;441:(7090):135
 
http://www.nature.com/doifinder/10.1038/441135a
HSL4627
 Stop Drug Ads
 Democracy in Action 2006 May 10
 
http://democracyinaction.org/dia/organizations/commercialalert/campaign.jsp?campaign_KEY=1415&t=stop_drug_ads_home.dwt
HSL4624
 Carlat D.
 Generic Smear Campaign 
 New York Times 2006 May 9
 
http://www.nytimes.com/2006/05/09/opinion/09carlat.html?th=&emc=th&pagewanted=print
HSL4629
 Fyfe M.
 Gift guide for doctors toughened
 The Age  (Melbourne) 2006 May 9
 
http://www.theage.com.au/news/national/gift-guide-for-doctors-toughened/2006/05/08/1146940475899.html
HSL5136
 Kondro W.
 Dispute over Vioxx study plays out in New England journal.
 
CMAJ 2006 May 9;174:(10):1397
 
http://www.cmaj.ca/cgi/content/full/174/10/1397
HSL5137
 Silversides A.
 Former director general: Health Canada needs broader drug safety powers.
 
CMAJ 2006 May 9;174:(10):1395-6
 
http://www.cmaj.ca/cgi/content/full/174/10/1395
HSL4518
 Herper M, Langreth R.
 Pill Pushers:  How the drug industry abandoned science for salesmanship. 
 Forbes.com 2006 May 8
 
http://www.forbes.com/forbes/2006/0508/094a_print.html
HSL4620
 Scheetz A.
 Variation of drug ads numbers  in JAMA
 2006 May 8
 
HSL4621
 Boseley S.
 Pill under review over link to depression  
 The Guardian ( UK) 2006 May 8
 
http://www.guardian.co.uk/frontpage/story/0,,1769935,00.html
HSL4625
 Lane S, Colvin M.
 New pharmaceutical guidelines criticised
 Australian Broadcasting Commission  ( Radio National - PM program) 2006 May 8
 
http://www.abc.net.au/pm/content/2006/s1633524.htm
HSL4626
 Adams C.
 Good science lacking for many `off-label' prescriptions, study finds
 Knight Ridder Newspapers 2006 May 8
 
http://www.mercurynews.com/mld/mercurynews/news/politics/14530736.htm
HSL4628
 Rubin R.
 Study: Off-label drugs often prescribed
 USA Today 2006 May 8
 
http://www.usatoday.com/news/health/2006-05-08-offlabel-drugs_x.htm
HSL4699
 Theobald B.
 Vaccine makers helped write Frist-backed shield law: E-mails reveal private meetings
 Tennessean online 2006 May 8
 
http://tennessean.com/apps/pbcs.dll/article?AID=/20060508/NEWS02/605080356
HSL4700
 Smith S.
 Some hospitals forgo baby-formula handout: State considers ban on gift bags
 Boston Globe 2006 May 8
 
http://www.boston.com/business/healthcare/articles/2006/05/08/some_hospitals_forgo_baby_formula_handout/
HSL5083
 Radley DC, Finkelstein SN, Stafford RS.
 Off-label prescribing among office-based physicians.
 
Arch Intern Med 2006 May 8;166:(9):1021-6
 
http://archinte.ama-assn.org/cgi/content/full/166/9/1021
HSL4622
 Wahlberg D.
 Outside income: UW's doctors needn't tell all
 Wisconsin State Journal 2006 May 7
 
http://www.madison.com/wsj/home/local/index.php?ntid=82989
HSL5085
 Stephens J.
 Panel faults Pfizer in '96 clinical trial in Nigeria.
 Washington Post 2006 May 7;A1,:
 
http://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html
HSL4635
 Dyer O.
 Watchdog gives spoof awards for aggressive marketing of drugs.
 
BMJ 2006 May 6;332:(7549):1050
 
http://bmj.bmjjournals.com/cgi/content/full/332/7549/1050-a
HSL4636
 Tuffs A.
 German law to cuts drug costs angers doctors.
 
BMJ 2006 May 6;332:(7549):1051
 
http://bmj.bmjjournals.com/cgi/content/full/332/7549/1051
HSL4637
 Patsopoulos NA, Ioannidis JP, Analatos AA.
 Origin and funding of the most frequently cited papers in medicine: database analysis.
 
BMJ 2006 May 6;332:(7549):1061-4
 
http://bmj.bmjjournals.com/cgi/content/full/332/7549/1061
HSL4638
 Delaney B.
 Is society losing control of the medical research agenda?
 
BMJ 2006 May 6;332:(7549):1063-4
 
http://bmj.bmjjournals.com/cgi/content/full/332/7549/1063
HSL4639
 Altman DG, Royston P.
 The cost of dichotomising continuous variables.
 
BMJ 2006 May 6;332:(7549):1080
 
http://bmj.bmjjournals.com/cgi/content/full/332/7549/1080
HSL4619
 Babington C.
 Out of a Son's Suicide, a New Mission
 Washington Post 2006 May 5
 
http://www.washingtonpost.com/wp-dyn/content/article/2006/05/04/AR2006050401685.html
HSL4908
 Ghosh P.
 Doubt cast over drug trial safety
 BBC News 2006 May 5
 
http://newsvote.bbc.co.uk/1/hi/health/4989810.stm
HSL5097
 Wilson N, Signal L, Nicholls S, Thomson G.
 Hazardous and beneficial nutritional messages in 858 televised food advertisements during children's viewing hours.
 
N Z Med J 2006 May 5;119:(1233):U1967
 
HSL4614
 Saul S.
 Doctors Object to Gathering of Drug Data
 New York Times 2006 May 4
 
http://www.nytimes.com/2006/05/04/business/04prescribe.html?pagewanted=1&_r=1
HSL4615
 Prescription Drugs | Pharmaceutical Company Advertisements Often False, Misleading, Report Finds
 kaisernetwork.org  ( The Henry J.  Kaiser Family Foundation) 2006 May 4
 
Pharmaceutical Company Advertisements Often False, Misleading, Report Finds 
HSL4616
 Baker D.
 Corruption in the Pharmaceutical Industry: Why Is Anyone Surprised?
 Beat th Press 2006 May 4
 
http://beatthepress.blogspot.com/2006/05/corruption-in-pharmaceutical-industry.html
HSL4617
 Abelson R.
 Too Soon to Breathe Easy? 
 New York Times 2006 May 4
 
http://www.nytimes.com/2006/05/04/business/04sinus.html
HSL5037
 Wood AJ, Darbyshire J.
 Injury to research volunteers--the clinical-research nightmare.
 N Engl J Med 2006 May 4;354:(18):1869-71
 
http://content.nejm.org/cgi/content/extract/354/18/1869
HSL5086
 Saul S.
 Doctors object as drug makers learn who's prescribing what.
 NY Times (Print) 2006 May 4;A1:
 
HSL4542
 McConnell  M.
 An open letter to Healthy Skepticism:
 2006 May 3
 
HSL4545
 Grady D.
 Study Finds Few Therapies Work Well on Hot Flashes
 New York Times 2006 May 3
 
http://select.nytimes.com/mem/tnt.html?tntget=2006/05/03/health/03hormone.html&tntemail1=y&_r=1&oref=login&emc=tnt&pagewanted=print
HSL4623
 Fallik D.
 Penn bans gifts from drug reps
 Philadelphia Inquirer 2006 May 3
 
http://www.philly.com/mld/philly/business/14485248.htm
HSL5038
 Strom BL.
 How the US drug safety system should be changed.
 JAMA 2006 May 3;295:(17):2072-5
 
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16670415&db=PubMed&url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=16670415
HSL4534
 Fyfe M.
 Trio slams cancer drugs 'gravy train'.
 The Age (Melbourne) 2006 May 2
 
http://www.theage.com.au/news/national/trio-slams-cancer-drugs-gravy-train/2006/05/01/1146335671089.html
HSL4535
 Companies 'overstep mark' to promote drugs
 ABC Online (Australia) 2006 May 2
 
http://www.abc.net.au/news/newsitems/200605/s1628456.htm
HSL4536
 Consumers’ Association Calls For Regulation of Drug Advertising
 Australian Consumers Association 2006 May 2
 
HSL4538
 Cresswell A.
 'Schmoozing' drug firms go too far
 The Australian Newspaper 2006 May 2
 
http://www.theaustralian.news.com.au/story/0,20867,18996609-23289,00.html
HSL4539
 Stafford A, Fyfe M.
 Drug firms accused over doctor 'perks'
 The Age  (Melbourne) 2006 May 2
 
http://www.theage.com.au/news/national/drug-firms-accused-over-perks/2006/05/01/1146335671080.html?page=fullpage#contentSwap1
HSL4544
 Altman L.
 For Science's Gatekeepers, a Credibility Gap
 New York Times 2006 May 2
 
http://www.nytimes.com/2006/05/02/health/02docs.html?ex=1304222400&en=989fce7c62c8e849&ei=5088&partner=rssnyt&emc=rss
HSL4612
 Turning Medicine into Snake Oil
 New Jersey Public Interest Research Group (NJPIRG) 2006 May 2
 
http://njpirg.org/reports/TurningMedintoSnakeOil.pdf
HSL4613
 Boodman S.
 'Natural' Guidance: Better Safety, Efficacy Data on Natural Medicines Are Now Available for a Fee, as Public Use Grows
 Washington Post 2006 May 2
 
http://www.washingtonpost.com/ac2/wp-dyn/NewsSearch?st=Data+on+Natural+Medicines&x=9&y=10&fn=&sfn=&sa=ns&cp=&hl=false&sb=-1&sd=&ed=&blt=
HSL4701
 Heavey S.
 Sick patients need access to drugs sooner: US court
 Reuters 2006 May 2
 
http://go.reuters.com/newsArticle.jhtml?type=healthNews&storyID=12041977
HSL6418
 Blackwell T.
 Free flu vaccine fails to reduce cases study: 'Rates haven't decreased and there's been lots of money spent'
 National Post 2006 May 2
 
HSL10046
 Elias M.
 New antipsychotic drugs carry risks for children
 USA Today 2006 May 2
 
http://www.usatoday.com/news/health/2006-05-01-atypical-drugs_x.htm
HSL2305
 Zoutman DE, Ford BD, Bassili AR
 Prescription data
 Canadian Medical Association Journal 2006 May 01;164:(10):1410-1409
 
HSL2323
 Sukkari  S, Sasich L D.
 Cisapride and patient information leaflets 
 Canadian Medical Association Journal 2001 May 01;164:(9):1276-1278
 
HSL4540
 Psychiatric drugs harming Canadians: report
 CBC News Online 2006 May 1
 
http://www.cbc.ca/story/science/national/2006/05/01/psychiatric-drugs060501.html
HSL4541
 SSRI antidepressants link to higher suicide risk in seniors
 CBC News Online 2006 May 1
 
http://www.cbc.ca/story/science/national/2006/05/01/ssri-suicide060501.html
HSL4974
 Shankar PR, Dubey AK, Subish P.
 Critical evaluation of drug promotion using role-plays.
 Med Educ 2006 May 01;40:(5):472
 
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2929.2006.02429.x
HSL5087
 [No authors listed].
 Second FDA panel advises on stimulants.
 Child Health Alert 2006 May 01;24:4:
 
HSL5138
 Baumgarten RK.
 Drug labels should evolve with medical knowledge.
 Anesthesiology 2006 May 01;104:(5):1107
 
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00035
HSL5139
 Moore DC.
 Labeling (package insert): meaning by the Food and Drug Administration of not recommended, not indicated, and off-label use.
 Anesthesiology 2006 May 01;104:(5):1107
 
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00036
HSL5140
 Sosis MB.
 Package inserts are a must read for anesthesiologists.
 Anesthesiology 2006 May 01;104:(5):1106
 
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3159&uid=16645469&db=PubMed&url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00034
HSL5148
 Grossman D, Ellertson C, Abuabara K, Blanchard K, Rivas FT.
 Barriers to contraceptive use in product labeling and practice guidelines.
 Am J Public Health 2006 May 01;96:(5):791-9
 
http://www.ajph.org/cgi/content/full/96/5/791
HSL5206
 Ziegler R.
 [Benefits and risks of drug industry 'sponsorship'].
  Med Monatsschr Pharm.2006 May;29(5):193-4 2006 May 01;29:(5):193-4
 
HSL5207
 Heinzl S.
 [The uses of clinical studies].
 Med Monatsschr Pharm 2006 May 01;29:(5):157
 
HSL5217
 Novas C.
 What is the bioscience industry doing to address the ethical issues it faces?
 PLoS Med 2006 May 01;3:(5):e142
 
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16573362
HSL5218
 Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA.
 Lessons on ethical decision making from the bioscience industry.
 PLoS Med 2006 May 01;3:(5):e129
 
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030129
HSL5391
 Dunn JD, Cannon E, Mitchell MP, Curtiss FR.
 Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
 J Manag Care Pharm 2006 May 01;12:(4):294-302
 
HSL5551
 Ohbayashi H.
 [Results of a survey questionnaire concerning smoking conditions in 54 major Japanese pharmaceutical companies and among their employees].
 Nihon Kokyuki Gakkai Zasshi 2006 May 01;44:(5):374-83
 
HSL5552
 Electronic chip fights counterfeiting.
 AIDS Patient Care STDS 2006 May 01;20:(5):380-1
 
HSL5562
 Ali MH, Kalima P, Maxwell SR.
 Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres.
 J Antimicrob Chemother 2006 May 01;57:(5):959-62
 
http://jac.oxfordjournals.org/cgi/content/full/57/5/959
HSL5563
 Gardarsdottir H, Heerdink ER, Egberts AC.
 Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.
 Pharmacoepidemiol Drug Saf 2006 May 01;15:(5):338-43
 
http://www3.interscience.wiley.com/cgi-bin/abstract/112466084/ABSTRACT?CRETRY=1&SRETRY=0
HSL5653
 Dresser R.
 Pharmaceutical company gifts: from voluntary standards to legal demands.
 Hastings Cent Rep 2006 May-Jun 01;36:(3):8-9
 
HSL5654
 Shiwani MH.
 Quest of prescribing practice in Pakistan.
 J Pak Med Assoc 2006 May 01;56:(5):249-50
 
HSL5664
 Brock DW.
 How much is more life worth?
 Hastings Cent Rep 2006 May-Jun 01;36:(3):17-9
 
HSL5668
 Collis MC.
 Integrative pharmacology and drug discovery--is the tide finally turning?
 Nat Rev Drug Discov 2006 May 01;5:(5):377-9
 
http://www.nature.com/nrd/journal/v5/n5/abs/nrd2036.html;jsessionid=2E66E474982DC1C9B107D97A21F5C060
HSL5669
 Mahecha LA.
 Rx-to-OTC switches: trends and factors underlying success.
 Nat Rev Drug Discov 2006 May 01;5:(5):380-5
 
http://www.nature.com/nrd/journal/v5/n5/abs/nrd2028.html
HSL5766
 Jayaraman J.
 Whose pen is in your pocket?
 Can Fam Physician 2006 May 01;52:586
 
HSL5767
 Cole D.
 Whose pen is in your pocket?
 Can Fam Physician 2006 May 01;52:586
 
HSL5768
 Williams R, Marion J.
 Are drug too expensive in Canada? No
 Can Fam Physician 2006 May 01;52:573-6, 578-81
 
HSL5769
 Lexchin J.
 Are drugs too expensive in Canada? Yes
 Can Fam Physician. 2006 May 01;52:573-6, 578-81
 
http://web.archive.org/web/20081201092146/http://www.cfpc.ca/cfp/2006/May/vol52-may-debates-1.asp?
HSL5770
 Noehrenberg E.
 Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.
 Bull World Health Organ 2006 May 01;84:(5):419-20
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500027&lng=en&nrm=iso&tlng=en
HSL5771
 Aoki R, Kubo K, Yamane H.
 Patent policy and public health in developing countries: lessons from Japan.
 Bull World Health Organ 2006 May 01;84:(5):417-8
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500026&lng=en&nrm=iso&tlng=en
HSL5772
 Winters DJ.
 Expanding global research and development for neglected diseases.
 Bull World Health Organ 2006 May 01;84:(5):414-6
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500025&lng=en&nrm=iso&tlng=en
HSL5773
 Maurer SM.
 Choosing the right incentive strategy for research and development in neglected diseases.
 Bull World Health Organ 2006 May 01;84:(5):376-81
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500017&lng=en&nrm=iso&tlng=en
HSL5774
 Lee ET, O'Riordan D, Swetter SM, Demierre MF, Brooks K, Geller AC.
 Sun care advertising in popular U.S. magazines.
 Am J Health Promot 2006 May-Jun 01;20:(5):349-52
 
HSL5775
 Burkitt JA, Saucier DM, Thomas NA, Ehresman C.
 When advertising turns 'cheeky'!
  Laterality 2006 May 01;11:(3):277-86
 
http://taylorandfrancis.metapress.com/(2l2xmgqnf5koknqxuljfhlax)/app/home/contribution.asp?referrer=parent&backto=issue,5,7;journal,4,47;linkingpublicationresults,1:101905,1
HSL5819
 Skomo ML, Desselle SP, Berdine HJ.
 Factors influencing migraineur-consulting behavior in a university population.
 Headache 2006 May 01;46:(5):742-9
 
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1526-4610.2006.00431.x
HSL5964
 Modernizing medical product development through collaboration.
 FDA Consum 2006 May-Jun 01;40:(3):5
 
http://www.fda.gov/fdac/departs/2006/306_upd.html
HSL5993
 Edwards M, Murray F, Yu R.
 Gold in the ivory tower: equity rewards of outlicensing.
 Nat Biotechnol 2006 May 01;24:(5):509-15
 
HSL5994
 Kamarck ME.
 Building biomanufacturing capacity--the chapter and verse.
 Nat Biotechnol 2006 May 01;24:(5):503-5
 
http://www.nature.com/nbt/journal/v24/n5/abs/nbt0506-503.html
HSL5995
 Saberwal G.
 New pharma-biotech company formation in India.
 Nat Biotechnol 2006 May 01;24:(5):499-501
 
http://www.nature.com/doifinder/10.1038/nbt0506-499b
HSL5996
 Ransom J.
 Are small biotechs still underselling themselves?
 Nat Biotechnol 2006 May 01;24:(5):477
 
http://www.nature.com/doifinder/10.1038/nbt0506-477
HSL6049
 Kids are different.
 Profiles Healthc Commun 2006 May-Jun 01;22:(3):20-4,
 
HSL6050
 GE Healthcare launches multiphase advertising effort.
 Profiles Healthc Commun 2006 May-Jun 01;22:(3):11-9,
 
HSL6051
 Michigan health system launches integrated campaign using patient testimonials.
 Profiles Healthc Commun 2006 May-Jun 01;22:(3):1-9,
 
HSL6084
 Bundesministerium fur Gesundheit.
 [Regulation for control of advertising cosmetic operations set into effect].
 Kinderkrankenschwester 2006 May 01;25:(5):211
 
HSL6138
 Service FJ.
 Idle thoughts from an addled mind. Caveat medicus.
 Endocr Pract 2006 May-Jun 01;12:(3):341
 
http://aace.metapress.com/(nlhpdn55bgfe0s45s03jwbas)/app/home/contribution.asp?referrer=parent&backto=issue,16,19;journal,4,79;linkingpublicationresults,1:300404,1
HSL6142
 Cowden AL, Katz KA.
 Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
 Br J Dermatol 2006 May 01;154:(5):950-8
 
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2006.07168.x
HSL6182
 Stagnaro JC.
 [The discovery of therapeutic properties of lithium].
 Vertex 2006 May-Jun 01;17:(67):225-30
 
HSL6183
 Bignone IM.
 [Issues regarding the legal regulation of drugs in Argentina].
 Vertex 2006 May-Jun 01;17:(67):220-3
 
HSL6268
 Shulman LP, Bateman LH, Creinin MD, Cullins VE, Doyle LL, Godfrey E, Murphy P, Rodriguez P, Spear SJ, Stewart FH, Thomas MA, Westhoff CL, Worthington S.
 Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
 Contraception 2006 May 01;73:(5):440-2
 
http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00034-5
HSL4610
 McCaughan , M .
 Time to pay the piper? Industry prepares for a fight over user fees.
 The RPM report 2006 May;1:(6):
 
http://www.windhover.com/ezine/pdf/UserFees0605.pdf
HSL4705
 Ban TA.
 Academic psychiatry and the pharmaceutical industry.
 
Prog Neuropsychopharmacol Biol Psychiatry 2006 May;30:(3):429-41
 
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16442686&db=pubmed&url=http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(05)00363-5
HSL5051
 Hu A, Chow CM, Dao D, Errett L, Keith M.
 Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement.
 
J Cardiovasc Nurs 2006 May-Jun;21:(3):169-75
 
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005082-200605000-00003
HSL5055
 Schneeman B, Trumbo P, Ellwood K, Satchell F.
 The regulatory process to revise nutrient labeling relative to the Dietary Reference Intakes.
 
Am J Clin Nutr 2006 May;83:(5):1228S-1230S
 
http://www.ajcn.org/cgi/content/full/83/5/1228S
Page 113 of 206 pages ‹ First < 111 112 113 114 115 > Last ›
 








 


